OBSCN and cutaneous melanoma: Within this expanded gene panel analysis, we identified a novel heterozygous germline variant of the tumor suppressor gene obscurin (OBSCN) in a 58-year-old female patient with a history of one primary cutaneous melanoma (Figure 1).